Time to redefine Myeloma
Guy Pratt(University Hospitals Birmingham NHS Foundation Trust), Jenny Bird, John A. Snowden(Sheffield Teaching Hospitals NHS Foundation Trust), Gordon Cook(University of Leeds), Matthew Streetly(St Thomas' Hospital), Roger G. Owen(Leeds Teaching Hospitals NHS Trust), Kwee Yong(CRUK Lung Cancer Centre of Excellence), Ashutosh Wechalekar(University College Hospital), Andrew Chantry(University of Sheffield), Karthik Ramasamy(Oxford University Hospitals NHS Trust), Nicola Mulholland(King's College Hospital), Graham Jackson(Newcastle College), Stella Bowcock(King's College Hospital), Maggie Lai(Myeloma UK), Eric Low(Myeloma UK), Neil Rabin(University College London)
Cited by 17
Related Papers
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma
|New England Journal of Medicine|2003|1.8k
Systemic amyloidosis
|The Lancet|2015|984
New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes
|Journal of Clinical Oncology|2012|965
Guidelines for the diagnosis and management of adult aplastic anaemia
|British Journal of Haematology|2015|750